Category: ACN Newswire

DENSO and TUV Rheinland Japan Sign Memorandum of Understanding to Realize Sustainable Product Development and to Promote Digital Product Passport

KARIYA, JAPAN, September 29, 2025 – (JCN Newswire via SeaPRwire.com) – DENSO CORPORATION (Headquarters: Kariya City, Aichi Prefecture; President: Shinnosuke Hayashi, hereinafter referred to as “DENSO”) and TÜV Rheinland Japan, Ltd. (Headquarters: Yokohama City, Kanagawa Prefecture; President: Kunihiro Okamoto, hereinafter referred

More

Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin

Hong Kong Department of Health accepts NDA for dorzagliatin, the world’s first approved glucokinase activator (GKA). Builds on China approval and strong Phase III and real-world clinical results showing durable glucose control and safety. Positions Hong Kong as a strategic

More

China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication

SHENZHEN, Sept 28, 2025 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiaries, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate

More